Across TCGA pan-cancer cohorts, TRAV39 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TRAV39 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher TRAV39 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRAV39 expression acts as an unfavorable survival marker.

KIRP are the cancer types where TRAV39 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.181	0.704	.009	8	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TRAV39 tumor-vs-normal RNA expression · all TRAV39 data types